Alector, Inc.

Alector, Inc.verified

ALEC

Price:

$5.82

Market Cap:

$566.41M

Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease; and AL003, which is in Phase I clinical trial for the treatment of Alzheimer's...[Read more]

Industry

Biotechnology

IPO Date

2019-02-07

Stock Exchange

NASDAQ

Ticker

ALEC

The Enterprise Value as of September 2024 (TTM) for Alector, Inc. (ALEC) is 554.98M

According to Alector, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 554.98M. This represents a change of 6.80% compared to the average of 519.65M of the last 4 quarters.

Alector, Inc. (ALEC) Historical Enterprise Value (quarterly & annually)

How has ALEC Enterprise Value performed in the past?

The mean historical Enterprise Value of Alector, Inc. over the last ten years is 973.44M. The current 554.98M Enterprise Value has changed 5.60% with respect to the historical average. Over the past ten years (40 quarters), ALEC's Enterprise Value was at its highest in in the June 2020 quarter at 1.87B. The Enterprise Value was at its lowest in in the March 2017 quarter at 0.

Quarterly (TTM)
Annual

Average

973.44M

Median

955.83M

Minimum

632.56M

Maximum

1.38B

Alector, Inc. (ALEC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Alector, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 30.97%

Maximum Annual Enterprise Value = 1.38B

Minimum Annual Increase = -52.85%

Minimum Annual Enterprise Value = 632.56M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023632.56M-2.71%
2022650.18M-52.85%
20211.38B17.09%
20201.18B15.23%
20191.02B-12.28%
20181.17B30.97%
2017889.57M2.11%

Alector, Inc. (ALEC) Average Enterprise Value

How has ALEC Enterprise Value performed in the past?

The current Enterprise Value of Alector, Inc. (ALEC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

887.27M

5-year avg

972.33M

10-year avg

973.44M

Alector, Inc. (ALEC) Enterprise Value vs. Peers

How is ALEC’s Enterprise Value compared to its peers?

Alector, Inc.’s Enterprise Value is greater than Passage Bio, Inc. (47.64M), greater than Black Diamond Therapeutics, Inc. (303.44M), greater than TCR2 Therapeutics Inc. (49.64M), less than Harpoon Therapeutics, Inc. (861.85M), less than Revolution Medicines, Inc. (7.20B), greater than Atreca, Inc. (-8620212.00), less than Stoke Therapeutics, Inc. (585.67M), greater than Homology Medicines, Inc. (-103303255.00), greater than Monte Rosa Therapeutics, Inc. (295.46M), greater than Cabaletta Bio, Inc. (25.15M), greater than Larimar Therapeutics, Inc. (402.70M),

Build a custom stock screener for Alector, Inc. (ALEC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alector, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alector, Inc. (ALEC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alector, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Alector, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Alector, Inc. (ALEC)?

What is the 3-year average Enterprise Value for Alector, Inc. (ALEC)?

What is the 5-year average Enterprise Value for Alector, Inc. (ALEC)?

How does the current Enterprise Value for Alector, Inc. (ALEC) compare to its historical average?